Biotechnology JournalSynthetic BiologyPeer-reviewed journal article
Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology
Fang BaiD, Yufei ZhangiD, Xiangyang JiiD, Wanqiu LiuiD, Shengjie LingiD, Jian LiiD
Abstract
Escherichia coli Nissle 1917 (EcN) is a probiotic microbe that has the potential to be developed as a promising chassis for synthetic biology applications. However, the molecular tools and techniques for utilizing EcN have not been fully explored. To address this opportunity, we systematically expanded the EcN-based toolbox, enabling EcN as a powerful platform for more applications. First, two EcN cryptic plasmids and other compatible plasmids were genetically engineered to enrich the manipulable plasmid toolbox for multiple gene coexpression. Next, we developed two EcN-based enabling technologies, including the conjugation strategy for DNA transfer, and quantification of protein expression capability. Finally, we expanded the EcN-based applications by developing EcN native integrase-mediated genetic engineering capabilities and establishing an in vitro cell-free protein synthesis (CFPS) system. Overall, this study expanded the toolbox for manipulating EcN as a commonly used probiotic chassis, providing several simplified, dependable, and predictable strategies for researchers working in synthetic biology fields. For Table of Contents Use Only O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=133 SRC="FIGDIR/small/543671v1_ufig1.gif" ALT="Figure 1"> View larger version (27K): org.highwire.dtl.DTLVardef@1f8e91forg.highwire.dtl.DTLVardef@90fb70org.highwire.dtl.DTLVardef@6badbforg.highwire.dtl.DTLVardef@15be840_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 25
- FWCI
- 2.22
- Field percentile
- top 11%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Engineering Escherichia coli Nissle as safe chassis for delivery of therapeutic peptides
Aarón Pantoja‐Angles, Zahir Ali, … Magdy M. Mahfouz·bioRxiv·Aug 30, 2025
- Construction of an engineered Escherichia coli with enhanced intestinal colonization and anti-inflammatory efficacy in colitis
Peijun Yu, Wenjing Zhou, … Yunpeng Yang·bioRxiv·Aug 1, 2025
- Engineering probiotic Escherichia coli Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system
- Enhancing the antibacterial function of probiotic Escherichia coli Nissle: when less is more
E. Bartram, M. Asai, … R. Wigneshweraraj·bioRxiv·Jun 9, 2023
- Engineering a novel probiotic toolkit in Escherichia coli Nissle1917 for sensing and mitigating gut inflammatory diseases
Nathalie Weibel, Martina Curcio, … Cauã Antunes Westmann·ACS Synthetic BiologyPeer-reviewed·Aug 8, 2024
- Awakening prime editing for precision engineering of probiotic Escherichia coli Nissle 1917
Pei-Ru Chen, Ying Wei, … Peng‐Fei Xia·Applied and Environmental MicrobiologyPeer-reviewed·Jan 31, 2025